CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
Avoiding burnout: A physician shares self-compassion strategies for provider wellness
Practicing self-compassion has never been more important for providers than during the COVID-19 pandemic, a CHOC oncologist writes.
Fertility future with testicular cryopreservation
The Hyundai Cancer Institute at CHOC is offers testicular preservation for prepubertal patients unable to bank sperm.
CHOC recognized as one of nation’s best children’s hospitals
CHOC is among a select group of pediatric facilities nationwide to be ranked as a best children’s hospital by U.S. News & World Report.
Testicular Cryopreservation bringing hope to CHOC cancer patients
Young male patients undergoing treatment for some cancers or blood disorders at CHOC Children’s have another hope for fertility preservation.
